Your browser doesn't support javascript.
loading
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.
Coles, Charlotte H; Mulvaney, Rachel M; Malla, Sunir; Walker, Andrew; Smith, Kathrine J; Lloyd, Angharad; Lowe, Kate L; McCully, Michelle L; Martinez Hague, Ruth; Aleksic, Milos; Harper, Jane; Paston, Samantha J; Donnellan, Zoe; Chester, Fiona; Wiederhold, Katrin; Robinson, Ross A; Knox, Andrew; Stacey, Andrea R; Dukes, Joseph; Baston, Emma; Griffin, Sue; Jakobsen, Bent K; Vuidepot, Annelise; Harper, Stephen.
Afiliação
  • Coles CH; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Mulvaney RM; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Malla S; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Walker A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Smith KJ; GlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom.
  • Lloyd A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Lowe KL; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • McCully ML; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Martinez Hague R; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Aleksic M; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Harper J; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Paston SJ; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Donnellan Z; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Chester F; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Wiederhold K; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Robinson RA; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Knox A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Stacey AR; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Dukes J; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Baston E; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Griffin S; GlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom.
  • Jakobsen BK; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Vuidepot A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.
  • Harper S; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and Stephen.Harper@immunocore.com bent.jakobsen@immunocore.com.
J Immunol ; 204(7): 1943-1953, 2020 04 01.
Article em En | MEDLINE | ID: mdl-32102902
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Receptores de Antígenos de Linfócitos T / Antígeno HLA-A2 / Antígenos de Histocompatibilidade Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Receptores de Antígenos de Linfócitos T / Antígeno HLA-A2 / Antígenos de Histocompatibilidade Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article